Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-11-22
2005-11-22
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007930, C435S009000, C435S345000, C436S514000, C436S015000, C436S547000
Reexamination Certificate
active
06967082
ABSTRACT:
The present invention relates to a monoclonal antibody suitable for monitoring the activity of systems involving protein C inhibitor, a method for preparation of the monoclonal antibody, a method for monitoring the activity of systems involving protein C inhibitor and a method for diagnosis of e.g. venous thrombosis, wherein the monoclonal antibody is utilized. The monoclonal antibody is suitable for monitoring the activity of systems involving protein C inhibitor, and it has specific affinity for both i) a complex between a serine proteinase and an inhibitor thereof, and ii) a cleaved and uncomplexed form of the inhibitor, but has substantially no specific affinity for the inhibitor in its uncleaved and uncomplexed form; or a derivative thereof having the same biological activity.
REFERENCES:
patent: 5834290 (1998-11-01), Egelrud et al.
patent: 2-236452 (1990-09-01), None
patent: WO 98/22509 (1998-05-01), None
Gaussem P et al. Journal of Biological Chemistry 1993 268: 12150-12155.
Poller et al. Journal of Biological Chemistry 1995 270: 2841-2845.
Kenneth A. Bauer et al., “Detection of Protein C Activation in Humans,”J. Clinical Invest. The American Society for Clinical Investigation, Inc.,vol. 74 (1984) pp. 2033-2041.
András Gruber et al., “Direct Detection of Activated Protein C in Blood From Human Subjects,”Blood,vol. 79, No. 9 (1992) pp. 2340-2348.
Francisco España et al., “Quantification of Circulating Activated Protein C in Human Plasma by Immunoassays—Enzyme Levels are Proportional to Total Protein C Levels,” Thrombosis and Haemostasis—F.K. Schattauer Verlagsgesellschaft mbH (Stuttgart) 75 (1) (1996) pp. 56-61.
Francisco España et al. “Determination of Functional and Antigenic Protein C Inhibitor and Its Complexes with Activated Protein C in Plasma by Elisa's,”Thrombosis Research,vol. 55 (1989) pp. 671-682.
Francisco España et al. “Determination of Plasma Protein C Inhibitor and of Two Activated Protein C-Inhibitor Complexes in Normals and in Patients with Intravascular Coagulation and Thrombotic Disease,”Thrombosis Researchvol. 59 (1990) pp. 593-608.
Kouzou Minamikawa et al. “Increased Activated Protein C-Protein C Inhibitor Complex Levels in Patients with Pulmonary Embolism,”Thrombosis and Haemostasis-F.K. Schattauer Verlagsgesellschaft mbH (Stuttgart) 71 (2) (1994) pp. 192-194.
Martin Laurell et al., “Monoclonal Antibodies Against the Heparin-Dependent Protein C Inhibitor Suitable for Inhibitor Purification and Assay of Inhibitor Complexes,” Thrombosis and Haemostasis—F.K. Schattauer Verlagsgesellschaft mbH (Stuttgart) 60 (2) (1988) pp. 334-339.
Ariane de Agostini et al., “A Common Neoepitope is Created When the Reactive Center of C1-Inhibitor is Cleaved by Plasma Kallikrein, Activated Factor XII Fragment, C1 Esterase, or Neutriphil Elastase,”J. Clin. Invest,vol. 82 (1988) pp. 700-705.
Shinji Asakura et al., “A Monoclonal Antibody That Triggers Deacylation of an Intermediate Thrombin-Antithrombin III Complex,”The Journal of Biological Chemistry,vol. 264, No. 23, (1989) pp. 13736-13739.
Ingemar Björk et al., “Immunologic Evidence for Insertion of the Reactive-Bond Loop of Antithrombin into the A β-Sheet of the Inhibitor During Trapping of Target Proteinases,” Biochemistry, vol. 32, (1993) pp. 6501-6505.
Ann-Kristin Öhlin et al., “Calcium-Dependent Interaction Between the Epidermal Growth Factor Precursor-Like Region of Human Protein C and a Monoclonal Antibody,”The Journal of Biological Chemistry,vol. 262, No. 28, (1987) pp. 13798-13804.
Carl A.K. Borrebaeck et al., “Production and Characterization of a Monoclonal Antibody Against the Seed Lectin of theDolichos biflorusPlant,”The Journal of Biological Chemistry,vol. 256, No. 10, (1981) pp. 4723-4725.
Martin Laurell et al., “Protein C Inhibitor in Human Body Fluids,”The American Society for Clinical Investigation, Inc.vol. 89, (1992) pp. 1094-1101.
Xuhua He et al., “Binding Site for C4b-Binding Protein in Vitamin K-Dependent Protein S Fully Contained in Carboxy-Terminal Laminin-G-type Repeats. A Study Using Recombinant Factor IX-Protein S Chimeras and Surface Plasmon Resonance,”Biochemistryvol. 36, No. 12, (1997) pp. 3745-3754.
Suzuki, Koji et al., “Characterization of a cDNA for Human Protein C Inhibitor”,The Journal of Biological Chemistry,Apr. 24, 1986, vol. 262, No. 2, The American Society of Biological Chemists, Inc., Bethesda, MD.
Gettins, Peter G. W., “Serpin Structure, Mechanism, and Function”,Chemical Reviews, vol. 102, No. 12, pp. 4751-4803, Department of Biochemistry & Molecular Genetics, Chicago, IL.
Huntington, James et al., “Crystal Structure of Protein C Inhibitor Provides Insights into Hormone Binding and Heparin Activation”,Structure,Feb., 2003, vol. 11, pp. 205-215, Elsevier Science, Ltd., Cambridge, MA.
Cheu Jacob
Forskarpatent I Syd AB
Le Long V.
LandOfFree
Monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3503897